Register for OBR daily


COA_AnnualConf_300x250

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

GERN $3.32 0.5100 +18.15%
PBYI $233.42 26.4600 +12.79%
PCYC $254.59 24.1100 +10.46%
MRTX $26.86 2.4600 +10.08%
BLRX $3.09 0.2500 +8.80%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

AVEO $1.44 -0.1050 -6.82%
AEZS $0.79 -0.0555 -6.59%
CALA $13.28 -0.7400 -5.28%
ABBV $57.30 -2.9700 -4.93%
MNKD $5.69 -0.2500 -4.21%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | Next > | Last >>

HRT Nearly Doubles the Risk of Ovarian Cancer, Experts Warn

(The Telegraph [UK]) Feb 13, 2015 - Women who undergo hormone replacement therapy, even for a short time, nearly double their risk of developing ovarian cancer, new research has warned.
read article 



NICE Rejects Celgene's Myeloma Drug Imnovid

(PharmaTimes [UK]) Feb 13, 2015 - Patients with multiple myeloma will not be able to access Celgene’s Imnovid (pomalidomide) on the National Health Service in England after cost-regulators issued a final draft ‘no’ for funding as a third-line treatment.
read article 



FDA Approves Lenvima For a Type of Thyroid Cancer

(FDA.gov) Feb 13, 2015 - The U.S. Food and Drug Administration today granted approval to Lenvima (lenvatinib) to treat patients with progressive, differentiated thyroid cancer (DTC) whose disease progressed despite receiving radioactive iodine therapy (radioactive iodine refractory disease).
read press release 



NICE Issues Final Draft Guidance on Pomalidomide For Blood Cancer

(NICE) Feb 13, 2015 - NICE has issued final draft guidance not recommending pomalidomide, also known as Imnovid, for treating multiple myeloma.
read press release 



J&J Creates New Research Efforts Targeting Disease Prevention

(Bloomberg) Feb 12, 2015 - Johnson & Johnson is starting three new research efforts, including a center focused on chronic diseases, with an eye toward identifying and stopping illnesses at the earliest stages or even before they start.
read article 



AstraZeneca Pays $7.9M to Settle Kickback Charge

(USA Today) Feb 11, 2015 - A U.S. division of British pharmaceutical giant AstraZeneca will pay the federal government $7.9 million to settle allegations the drug manufacturer and distributor engaged in a kickback scheme to boost sales of one of its popular medications.
read article 



Stroke Procedure to Pluck Clots From Brain Betters Recovery Odds

(Bloomberg) Feb 11, 2015 - Stroke patients are more likely to recover if doctors quickly perform a minimally invasive procedure to restore blood flow to the brain and remove damaging clots, rather than using clot-busting drugs alone, two new studies have found.
read article 



Smoking's Death Toll May Be Higher Than Anyone Knew

(NPR/Shots blog) Feb 12, 2015 - The U.S. surgeon general lists 21 deadly diseases that are caused by smoking.
read article 



More Than Half of Meaningful Use Penalties Will Be Under $1K

(Medscape Medical News) Feb 11, 2015 - The majority of physicians who are being penalized this year for not having met meaningful use requirements in previous years will forfeit less than $1000 of their Medicare reimbursement, according to data just released by the Centers for Medicare & Medicaid Services (CMS).
read article (free registration required) 



Experts Warn 2015 Could Be 'Year of the Healthcare Hack'

(Reuters) Feb 11, 2015 - Security experts are warning healthcare and insurance companies that 2015 will be the "Year of the Healthcare Hack," as cybercriminals are increasingly attracted to troves of personal information held by U.S. insurers and hospitals that command high prices on the underground market.
read article 



Florida Cancer Specialists & Research Institute Expands Clinical Trial Research Program in Palm Beach County

(FCS) Feb 10, 2015 - Florida Cancer Specialists & Research Institute (FCS), the leading community oncology practice in Florida, is pleased to announce an expansion of its clinical trial research program into Palm Beach County.
read press release 



New Data From FoundationOne® Demonstrates Genomic Basis For Potential New Routes to Therapy and Improved Outcomes For Individuals With Cancers of Unknown Primary

(TheStreet) Feb 12, 2015 - Foundation Medicine, Inc. today announced that new data utilizing FoundationOne® was published in the inaugural issue of JAMA Oncology.
read article 



FDA Takes Steps to Simplify Compassionate Use Process, Invites Comment

(ASCO in Action) Feb 11, 2015 - The U.S. Food and Drug Administration (FDA) introduced a more streamlined form for requesting permission for patient access to investigational drugs outside of clinical trials.
read article 



Suit Seeks to Exempt Physicians From Assisted Suicide Law

(New York Times/Associated Press) Feb 11, 2015 - A cancer patient and five doctors filed a lawsuit Wednesday seeking to exempt physicians who help terminally ill patients end their lives from a California ban on assisted suicide.
read article 



Axium Launches New Oncology Management Program For MSHO Members

(Axium) Feb 10, 2015 - Axium, a member of the Kroger Company’s family of pharmacies, as well as a corporate member of the Michigan Society of Hematology & Oncology (MSHO), has launched a new effort that immediately places one of the nation’s most innovative specialized oncology therapy programs into the hands of MSHO members.
read corporate press release 



AMP and CAP Formalize Collaboration to Advance Molecular and General Pathology

(CNBC) Feb 12, 2015 - The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular laboratory professionals, together with the College of American Pathologists (CAP) announced today the signing of memorandum of understanding to foster synergies between the sub-specialty of molecular pathology and the general practice of pathology.
read article 



Takeda Jury Told Actos Responsible For Man’s Cancer

(Bloomberg) Feb 11, 2015 - Takeda Pharmaceutical Co. should be held responsible for failing to warn about the bladder-cancer risks tied to its Actos diabetes drug, a Pennsylvania jury was told by the lawyer for former school teacher.
read article 



Eisai Expects New Cancer Drug to Bring in $1 Billion a Year by 2020

(Wall Street Journal) Feb 12, 2015 - Eisai Co. said it expects its new drug for thyroid and other cancers to bring in more than $1 billion a year by 2020.
read article (paid subscription required) 



Aileron Therapeutics Initiates Phase 1 Cancer Study of ALRN-6924 in Advanced Hematologic and Solid Malignancies with Wild Type p53

(Yahoo! Finance) Feb 12, 2015 - Aileron Therapeutics, Inc., a clinical stage biopharmaceutical company that is the leader in the emerging field of stapled peptide drug development, announced today that the first cancer patients have been dosed in a Phase 1 clinical trial of ALRN-6924.
read article 



Spectrum Pharmaceuticals Highlights Clinical Data For Captisol-Enabled™ (Propylene Glycol-Free) Melphalan at the 2015 BMT Tandem Meeting

(TheStreet) Feb 12, 2015 - Spectrum Pharmaceuticals today announced results of a clinical study of Propylene Glycol (PG)-Free, Captisol-enabled Melphalan (CE Melphalan) Conditioning for Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Multiple Myeloma (MM).
read article 



Study: Young Adult Survivors Most Distressed After Leukemia and Lymphoma Treatment

(UCCC/In the Clinic blog) Feb 11, 2015 - Two University of Colorado Cancer Center studies published in the Journal of Psychosocial Oncology show that young adult survivors (ages 18-39) of leukemia and lymphoma are more likely to report high distress than older survivors (ages 65+).
read article 



First-in Man: Tumor Suctioned From Vein to Allow For Kidney Surgery

(Henry Ford Health System) Feb 11, 2015 - Physicians at Henry Ford Hospital successfully suctioned a cancerous tumor from a major vein in a patient with metastatic kidney cancer, clearing the way for him to undergo a minimally-invasive kidney removal.
read press release 



Mutation Order in Tumor Genes Affects Cancer Outcome

(Scientific American) Feb 11, 2015 - For the first time, researchers have proved that the order in which cancer genes mutate affects the type of malignancy that results and its response to treatment.
read article 



Stroke Survivors May Be at Higher Risk of Having Cancer

(American Heart Association) Feb 12, 2015 - People who had a stroke may develop cancer at a higher rate than those who do not have a stroke, according to research presented at the American Stroke Association’s International Stroke Conference 2015.
read press release 



Lenvatinib Highly Beneficial in Advanced Thyroid Cancer

(Medscape Medical News) Feb 11, 2015 - The investigational agent lenvatinib significantly increased progression-free survival and response rates in patients with iodine-131 refractory thyroid cancer in a phase 3 trial.
read article (free registration required)